Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or the person is pregnant, or is planning to become pregnant. For more information, see the NICE guideline on diabetes in pregnancy. [new 2015] Do not do recommendation December 2016
Do not offer aspirin for the primary prevention of cardiovascular disease to adults with type 1 diabetes. Do not do recommendation December 2016
Iron supplementation should not be offered routinely to all pregnant women. It does not benefit the mother's or the baby's health and may have unpleasant maternal side effects. Do not do June 2016 Unclassified
The effectiveness and safety of oral treatments for vaginal candidiasis in pregnancy are uncertain and these treatments should not be offered. Do not do June 2016 Unclassified
Routine breast examination during antenatal care is not recommended for the promotion of postnatal breastfeeding. Do not do June 2016 Unclassified
Routine antenatal pelvic examination does not accurately assess gestational age, nor does it accurately predict preterm birth or cephalopelvic disproportion. It is not recommended. Do not do June 2016 Unclassified
Routine screening for cardiac anomalies using nuchal translucency is not recommended. Do not do June 2016 Unclassified
When routine ultrasound screening is performed to detect neural tube defects, alpha-fetoprotein testing is not required. Do not do June 2016 Unclassified
The routine anomaly scan (at 18 weeks 0 days to 20 weeks 6 days) should not be routinely used for Down's syndrome screening using soft markers. Do not do June 2016 Unclassified
The presence of an isolated soft marker, with the exception of increased nuchal fold, on the routine anomaly scan, should not be used to adjust the a priori risk for Down's syndrome. Do not do June 2016 Unclassified